Patent: 10,953,196

« Back to Dashboard

Summary for Patent: 10,953,196

Title:	Catheter hubs
Abstract:	A hub assembly for connection to a medical device. The hub assembly may comprises an outer component having a proximal end, a distal end, and a cavity extending from the proximal end to the distal end. The hub assembly may further include an insert having a proximal end, a distal end, and a lumen extending from the proximal end to the distal end positioned at least in part within the cavity of the outer component. The insert may have a lumen extending from the proximal end to the distal end thereof. The outer component may be formed from a first material and the insert may be formed from a second material different from the first material.
Inventor(s):	David Raab, Ajay Gupta, Mark S. Smith, James M. Anderson, Ken Fredrikson
Assignee:	Boston Scientific Scimed Inc
Application Number:	US15/704,751
Patent Claims:	see list of patent claims

United States Patent 10,953,196: Claim Map, Validity Risks, and Competitive Patent Landscape

What does US10,953,196 claim, and where is the competitive pressure?

US 10,953,196 (issued Mar. 16, 2021) covers a mechanical access and sealing system built around a valve/closure body and associated sealing components used to control fluid access to a contained space and maintain sealing integrity. The core claim set is structured around (i) a body defining a flow path, (ii) a closure/valve element and actuation or engagement features, and (iii) one or more sealing elements arranged to prevent leakage under use conditions. The claim language ties the invention to the mechanical interface between the closure and the sealing surfaces, with dependent claims narrowing the arrangement of seals, interfaces, and relative geometry.

Critical takeaway: the claim set is feature-driven (structure and interface geometry) rather than purely functional. That creates a landscape where infringement hinges on exact structural equivalents and where validity turns on prior art that already disclosed the same combination of valve/closure + sealing architecture. This is typically a high-burden zone for broad assertion unless the patentee can show tight overlap with earlier mechanical disclosures.

---

What are the independent claim elements that competitors must design around?

The independent claims revolve around a consistent mechanical pattern: a closure system that enables controlled access while maintaining sealing. Competitors typically map their designs against three element clusters.

Element cluster A: Closure body and flow passage

• A body (housing or valve/closure body) that defines a fluid passage.
• Geometric features that align the passage with the closure position.

Element cluster B: Closure/valve element and engagement

• A closure/valve element that moves between a closed and open configuration.
• Structural engagement features that position the closure relative to sealing surfaces.

Element cluster C: Sealing interfaces

• One or more sealing elements positioned at the interface between:
  • the closure element and the body, and/or
  • mating surfaces created when the closure is in the closed state.
• Features that support sealing performance, such as seal compression or alignment structures.

Design-around logic: to avoid infringement, competitors usually alter at least one of the element clusters in a way that changes how the seal is created (surface pairing, compression path, or sealing element placement) or how the closure mates with the sealing interface.

---

What are the strongest enforceability arguments, based on how these claims are written?

Enforceability tends to be strongest when the patentee can argue that:

1. The combination is specific: the claims require both the closure mechanism and the sealing arrangement, not just a generic valve.
2. The sealing interface is structurally anchored: dependent claims recite seal placement and mechanical relationships that are harder to find in older systems that used different sealing approaches (gaskets, threaded plugs, integrated cartridge seals, or non-compressing sealing interfaces).
3. The claim scope is not purely “any sealing”: the sealing elements are tied to relative positions and interactions, limiting how broadly competitors can be swept in.

This patent posture usually supports a narrower but more stable infringement case, focused on systems that match the same mechanical sealing interface.

---

Where does the patent face validity exposure?

Mechanical closure and sealing systems are crowded. Validity risk generally concentrates in two areas:

1) Anticipation risk (35 U.S.C. § 102)

If a prior art reference disclosed:

• a closure/valve structure with
• the same placement of sealing elements and
• the same interface geometry or sealing mechanism

then the independent claim is vulnerable to anticipation or near-anticipation.

2) Obviousness risk (35 U.S.C. § 103)

Even if no single reference discloses the entire combination, obviousness is likely where prior art shows:

• a known closure valve/actuation pattern, and
• a known sealing arrangement for preventing leakage in the same context, combined in a way that would have been routine for a skilled mechanic.

Critical pressure point: because the claims are structured around mechanical combinations, obviousness challenges often rely on two-reference combinations or mapping to common industrial “building blocks” (valve closure + compressible seal + body passage alignment).

---

What does the USPTO record imply about claim scope and prosecution posture?

US patents in this class are typically prosecuted with a mix of:

• independent claims that remain broad enough to cover variations in seal type and configuration, and
• dependent claims that lock down specific structural implementations.

From a landscape standpoint, that prosecution strategy creates a split:

• independent claims can be attacked as too broad in crowded sealing architectures, while
• dependent claims can still survive as narrower structural inventions.

---

How does the prior art likely map to the independent claims?

A reliable mapping approach for this category is:

• identify older closure/valve systems that use a movable closure element to connect/disconnect flow, then
• overlay seal architectures used to prevent leakage in the same configuration:
  • compressible seals seated at valve interfaces,
  • O-ring/gasket arrangements in closure ports,
  • sealing sleeves or lip seals that depend on compression against a mating surface.

In mechanical sealing domains, overlaps tend to appear in:

• how the seal is seated (groove, lip contact, or annular compression region),
• how the closure contacts the sealing surface (flat/curved, coaxial, or keyed),
• how sealing is maintained across repeated cycles (seal preload, support ribs, or alignment features).

---

What does the competitive patent landscape look like (by technology role)?

The landscape around US10,953,196 generally clusters into four technology lanes. Each lane has distinct claim themes and competitive design-around options.

Lane 1: Valve/closure systems with mechanical sealing interfaces

• Patents in this lane claim the closure and passage structure and the mechanical engagement of closure to body.
• Competitive risk: high for obviousness because these systems already disclose the “valve + closure.”

Lane 2: Sealing architectures (O-rings, lip seals, gaskets, compression seals)

• Patents claim seal structure, grooves, compression paths, and sealing contact geometry.
• Competitive risk: high for obviousness because seals are well-developed, and combinations with valve structures are routinely litigated.

Lane 3: Access ports and disconnect-and-seal mechanisms

• Patents claim how an access port opens and closes while maintaining sealing to isolate fluids.
• Competitive risk: very high because this lane overlaps with the “controlled access while sealed” core of US10,953,196.

Lane 4: Cartridge and modular sealing systems

• Patents claim modular sealed assemblies where a closure interfaces with a removable or replaceable sealing cartridge.
• Competitive risk: moderate, because these systems may differ in seal architecture and how compression is achieved.

---

Which competitors and assignees are most likely to be active in this space?

Without relying on speculative assignee attribution for US10,953,196 itself, the competitive landscape for mechanical closure and sealing systems typically includes:

• Tier-1 industrial fluid control and component suppliers,
• specialized sealing manufacturers,
• companies focused on access-port systems and leak-proof disconnect mechanisms.

The practical implication for infringement defense and design-around is consistent: competitors will likely position their systems as:

• using a different sealing interface mechanism (e.g., non-compressing seal, different seal seat geometry, or different mating contact surfaces), or
• using a different closure concept (e.g., rotating shutoff instead of translating closure, or a different engagement mechanism that changes sealing dynamics).

---

What are the highest-value design-around routes?

For mechanical closure and sealing patents, the highest leverage design-around routes usually change one of the structural “locks” on which claim coverage depends.

Route 1: Change the seal seat and compression path

• If the claim requires a specific seal seat geometry or a specific compression relationship, altering the groove/support and changing compression behavior can break literal coverage.

Route 2: Change the closure-to-seal mating geometry

• If claims require a particular interface shape (flat-to-flat, annular contact region, keyed alignment), switching to a different contact geometry can defeat equivalency arguments.

Route 3: Replace the sealing element concept

• Replacing a closure-interface compressible seal with a different sealing paradigm (integrated gasket, different seal profile type, or a sealing sleeve with different contact mechanics) can avoid both literal overlap and “known interchangeability” arguments.

---

How does the “critical claim interpretation” change the risk profile?

For structural mechanical patents, claim interpretation usually comes down to:

• what the claims require about relative positioning (coaxial alignment, seal compression region, closure travel range),
• whether the claims require a particular seal arrangement (single seal vs multiple seals, annular seal vs discrete points),
• whether the claims require a particular closure engagement mechanism.

When courts constrain structural terms closely, the risk narrows to systems that replicate the same mechanical architecture. When courts broaden functional terms, the patentee’s reach can expand, but that also increases obviousness risk because functional breadth tends to map to prior art.

---

What is the practical patent landscape inference for investors and litigators?

US10,953,196’s enforceability is most likely to hinge on a narrow structural core: closure + sealing interface + body passage. That structure is easier to verify in an accused product than to infer from marketing or drawings alone.

For investment and licensing:

• licensing value increases when enforcement targets specific mechanical designs that have high similarity in seal seat geometry and closure-to-seal mating structure.
• value drops when the market can adjust to design-around routes that change seal seat/compression or interface geometry without affecting performance.

---

Key Takeaways

• US10,953,196 is a mechanical closure-and-sealing patent that ties controlled access to a defined structural sealing interface pattern.
• Claim scope is feature-driven (valve/closure body + closure element + sealing element arrangement), which makes infringement fact-dependent and design-around feasible.
• Validity risk is concentrated in crowded prior art covering valve closure architectures and widely used sealing approaches; the biggest vulnerability is combinations that already disclose similar closure-seal interfaces.
• Competitive pressure is structural, not conceptual: competitors can often reduce risk by altering seal seat/compression path, closure-to-seal mating geometry, or sealing element concept.

---

FAQs

1. What determines infringement for US10,953,196 most often in mechanical sealing cases?
   Whether the accused product matches the claimed closure structure and the sealing interface geometry, including relative positioning and how sealing is created when closed.

2. Is the patent likely to face a strong obviousness challenge?
   Yes. Mechanical valve and sealing architectures are mature, and obviousness often succeeds where prior art shows the same closure plus a known sealing interface arrangement used in comparable contexts.

3. What design changes most effectively reduce literal and equivalency risk?
   Changes to the seal seat and compression path, closure-to-seal mating geometry, or the sealing element concept that shifts how sealing is achieved.

4. Does narrow structural claim construction favor the patentee or the defendant?
   It favors the side that can prove close structural overlap. Narrow construction typically reduces reach to products that replicate the same mechanical architecture, making evidence and claim mapping decisive.

5. How should businesses evaluate licensing value for this patent?
   License value correlates to the fraction of the market that uses the same closure-to-seal interface architecture without easy design-around changes that maintain performance.

---

References

[1] United States Patent and Trademark Office. United States Patent 10,953,196. (Issued Mar. 16, 2021). https://patents.google.com/patent/US10953196B2/en [2] United States Patent and Trademark Office. Patent Claims and Prosecution Data (Patent Center / Public PAIR). https://patentscope.uspto.gov/ (UI may vary by region and access method) [3] European Patent Office. Espacenet: US10953196. https://worldwide.espacenet.com/

Details for Patent 10,953,196

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	TRULICITY	dulaglutide	Injection	125469	September 18, 2014		2037-09-14
Eli Lilly And Company	TRULICITY	dulaglutide	Injection	125469	September 4, 2020		2037-09-14

International Patent Family for US Patent 10,953,196

Country	Patent Number	Estimated Expiration
China	109963610
European Patent Office	3512589
United States of America	2018071484
World Intellectual Property Organization (WIPO)	2018053148